26.07.2012 • News

Clariant to Acquire Remaining Share of Ukrainian Catalyst Joint Venture

The Swiss specialty chemicals group Clariant has signed an agreement to acquire the remaining 40% share of a joint venture between the Holding company Alvigo, based in Tallin/Estonia and Süd-Chemie, in the meantime acquired by Clariant.

The Süd-Chemie Alvigo Catalysts (SCAC) is a producer of syngas catalyst, based in the Ukraine. The signing of the transaction took place at the end of June, closing is subject to merger control approval. The purchase price has not been disclosed.

 

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read